Advent Life Sciences

company

About

Advent Life Sciences is a venture capital firm investing in life sciences businesses.

  • 11 - 50

Details

Industries
Finance,Financial Services,Venture Capital
Founded date
Jan 1, 2009
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Venture Capital

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences, principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Investments

Number of Investments
Number of Lead Investments
13
5
Advent Life Sciences has made 13 investments. Their most recent investment was on Sep 15, 2022, when Tridek-One raised €16M.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 15, 2022 Tridek-One
Series Unknown €16M Biotechnology
Apr 25, 2022 Epitopea
Seed £10.30M Biotechnology
Mar 22, 2021 Aura Biosciences
Series Unknown $80M Biotechnology
Series B $53M Biopharma
Series A $7.50M Biopharma Yes